News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|April 18, 2012

VIDEO: David Nau, PhD, Speaks about Quality Improvement Models

In this video, David Nau, PhD, RPh, CPHQ, Senior Director, Quality Strategies Pharmacy Quality Alliance, Inc, discusses quality improvement models.

In this video, David Nau, PhD, RPh, CPHQ, Senior Director, Quality Strategies Pharmacy Quality Alliance, Inc, discusses quality improvement models.

This video was taken on Wednesday, April 18, 2012, at the 24th Annual Academy of Managed Care Pharmacy Conference in San Francisco, CA.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

February 6th 2026

The OCEANIC-STROKE subgroup analysis findings, in tandem with the main results presented at ISC 2026, suggest that targeting factor XIa could be a safe way to intensify antithrombotic therapy following noncardioembolic stroke, regardless of underlying etiology. | Image credit: jolygon - stock.adobe.com

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

February 6th 2026

Luke Messac at ISC 2026

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

BySkylar Jeremias,Luke Messac, MD, PhD

February 6th 2026

GLP-1 agonists remain largely untested in this at-risk patient population and warrant further research, experts said. | Image credit: mingnimit - stock.adobe.com

How Do GLP-1 Agonists Fit Into Stroke Care?

February 6th 2026

Ava Liberman at ISC 2026

Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD

BySkylar Jeremias

February 5th 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text